Evidence map›Paper›PMID 40608790›Full record

ArticlePloS one2025

Association of environmental enteropathy with prediabetes and diabetes: A cross-sectional study among Tanzanian adults.

George PrayGod, Belinda Kweka, Evangelista Malindisa, Andrea M Rehman, Ruth Frikke-Schmidt, Christina Christoffersen, Rikke Krogh-Madsen, Daniel Faurholt-Jepsen, Henrik Friis, Paul Kelly and 1 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

George PrayGodMuhimbili Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0002-0329-4839
Belinda KwekaMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.
Evangelista MalindisaDepartment of Physiology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.ORCID https://orcid.org/0000-0002-0560-954X
Andrea M RehmanFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-9967-5822
Ruth Frikke-SchmidtDepartment of Clinical Medicine, University of Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-4084-5027
Christina ChristoffersenDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
Rikke Krogh-MadsenDepartment of Clinical Medicine, University of Copenhagen, Denmark.
Daniel Faurholt-JepsenDepartment of Clinical Medicine, University of Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-8561-0155
Henrik FriisDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
Paul KellyUniversity Teaching Hospital, Lusaka, Zambia.
Suzanne FilteauFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEnvironmental enteropathy (EE) may increase the risk of diabetes, but data are limited. We assessed the role of EE on markers of glucose metabolism.

methodsCross-sectional study among Tanzanian adults assessing EE and diabetes was conducted between 2019 and 2021. Data on demography, body mass index (BMI), Human immunodeficiency virus (HIV), EE (i.e., fecal myeloperoxidase, lipopolysaccharide binding protein, and markers of intestinal permeability and absorption capacity), glucose and insulin were collected. Data reduction using principal components analysis produced two components: sugar uptake and inflammatory EE. Tertiles were used to define EE severity as: lower, middle, and upper. The main outcome, combined prediabetes and diabetes, was defined as 2-hour oral glucose tolerance test (OGTT) glucose ≥7.8 mmol/L. Lower homeostatic model assessment (HOMA)-β and insulinogenic index, higher HOMA-insulin resistance (HOMA-IR), and lower Matsuda index were secondary outcomes. Logistic regression assessed the associations and HIV and BMI groups were tested as effect modifiers.

resultsA total of 612 participants were included. The mean (±SD) age was 42.0 (±11.6) years and 57.2% (350) were females. Eighty (13%) were underweight, 367 (60%) normal weight, 165 (27%) overweight, and 357 (58%) were HIV-infected. We found no overall association of EE on the main outcome, but BMI and HIV modified the associations. Compared to lower tertile of sugar uptake EE, the upper tertile was associated with marginally significant higher odds of prediabetes and diabetes (OR=2.1 (95% CI: 0.9, 4.9; P = 0.06)) and marginally significant higher HOMA-IR (OR=2.6 (1.0, 6.8; P = 0.06)) among overweight and obese participants. Similarly, compared to the lower tertile, the upper tertile of inflammatory EE was associated with higher odds of prediabetes and diabetes (OR=2.1 (1.1, 4.1; P = 0.03)) among HIV-uninfected participants, whereas among HIV-infected participants those in the middle tertile compared to those in the lower tertile had higher odds of lower Matsuda index (OR=2.3 (1.1, 4.7; P = 0.03)).

conclusionsEE may increase the risk of prediabetes and diabetes among those who are overweight and in individuals who are not HIV-infected. Longitudinal studies on the role of EE on diabetes are needed to confirm these results to provide the basis for developing and testing novel interventions to combat diabetes in Africa.

Indexed as

Diabetes MellitusIntestinal DiseasesPrediabetic StateAdultBlood GlucoseBody Mass IndexCross-Sectional StudiesFemaleGlucose Tolerance TestHIV InfectionsHumansInsulin ResistanceMaleMiddle AgedTanzaniaBlood Glucose

Identifiers

PMID40608790
PMCPMC12225851

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.